2,5-DMA
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| PsychonautWiki | Pharmacology | PiHKAL | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | 2,5-DMADOH | — | DMA2,5-DIMETHOXYAMPHETAMINE | ≠ |
| Safety | ||||
| Addiction potential | not habit-forming | — | — | |
| Toxicity | toxic dose is unknown | — | — | |
| Dangerous interactions | — | — | ||
| Unsafe interactions | — | — | ||
| Dose · Oral | ||||
| Threshold | 10 mg | — | — | |
| Light | 10–40 mg | — | — | |
| Common | 40–80 mg | — | 80–160 mg | ≠ |
| Strong | 80–200 mg | — | — | |
| Heavy | 200 mg+ | — | — | |
| Duration | ||||
| Total | 6–8 hours | — | 6–8 hours | = |
| Pharmacology | ||||
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
Duration at a glance
Total duration on one shared scale.
PiHKAL summary
Human reports on this compound are scarce and mostly discouraging. The author got no further than a mild threshold response at 80 mg, an experience consisting entirely of tremor and cardiovascular pressure with no sensory component at all. A separate 75 mg trial was described as gently pleasant, bringing greater curiosity about the immediate environment yet neither altered perception nor real stimulation.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.